Our goal is to transform cutting-edge science into groundbreaking therapies of tomorrow.

The word Invenio is derived from the Latin word "to discover".  At Invenio, that's what we aim to do – to discover novel therapies and deliver them to patients who are waiting in need.

Invenio partners with early-stage biotech companies to turn innovative concepts into clinical reality.

Specializing in biotherapeutic drug discovery strategy and execution, we can help operationalize every step of the way – from early research and screening, to identifying development candidates for IND-enabling activities and beyond.

With a deep understanding of the biotherapeutics landscape, Invenio offers tailored strategies, practical insights, and hands-on support. We empower data-driven decisions and phase-appropriate risk mitigation to accelerate and move confidently from discovery to development. 

We have vast expertise with CRO management to enable antibody discovery, engineering and optimization utilizing a variety of platforms.  We can help you develop and execute your discovery campaign to leverage cutting-edge technologies, including in vivo immunizations (hybridoma & B cell cloning), in vitro display (phage & yeast), molecular modeling & rational design.


Contact us:
info@invenio-consulting.com

Invenio Consulting

Org chart

Teams

Offices